Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.
Alroughani R, Ashkanani A, Lamdhade S.
Int J Neurosci. 2012 Feb;122(2):82-7. Epub 2011 Nov 15.
Related citations
Establishing an evaluation scale for the perception of quality of life related to relapsing-remitting forms of multiple sclerosis and feasibility study.
Baroin A, Mokadym H, Chopard G, Lavier A, Berger E, Rumbach L, Rude N.
Int J Neurosci. 2012 Jan;122(1):9-16. doi: 10.3109/00207454.2011.613549. Epub 2011 Sep 26.
Investigation of CD24 and Its expression in iranian relapsing-remitting multiple sclerosis.
Kollaee A, Ghaffarpor M, Pourmahmoudian H, Shahbazi M, Zamani M.
Int J Neurosci. 2011 Dec;121(12):684-90. Epub 2011 Sep 12.
Screening for well-characterized paraneoplastic antineuronal antibodies in multiple sclerosis.
Stich O, Murek C, Rasiah C, Rauer S.
Int J Neurosci. 2011 Aug;121(8):477-9. Epub 2011 Jun 10.
Torque teno mini virus infection and multiple sclerosis.
Komijani M, Bouzari M, Etemadifar M, Zarkesh-Esfahani H, Shaykh-Baygloo N, Ghazimorad A, Mostajeran M, Nasr-Azadani A, Maghzi AH.
Int J Neurosci. 2011 Aug;121(8):437-41. Epub 2011 May 6.
Prevalence of multiple sclerosis in Dubai, United Arab Emirates.
Inshasi J, Thakre M.
Int J Neurosci. 2011 Jul;121(7):393-8. Epub 2011 Apr 4.
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East.
Deleu D, Alsharoqi I, Al Jumah MA, Al Tahan AR, Bohlega S, Dahdaleh M, Inshasi J, Khalifa A, Szólics M, Yamout BI.
Int J Neurosci. 2011 Apr;121(4):171-5. Review.
Examination of the relationship between average plaque volume and clinical and demographic characteristics in multiple sclerosis patients using a stereological method.
Terzi M, Yilmaz E, Sahin B, Kaplan S, Onar M.
Int J Neurosci. 2011 Jul;121(7):366-72. Epub 2011 Mar 23.
Antineuronal antibodies in migraine patients with white matter lesions.
Türkoğlu R, Tüzün E, Içöz S, Birişik O, Erdağ E, Kürtüncü M, Akman-Demir G.
Int J Neurosci. 2011 Jan;121(1):33-6. Epub 2010 Oct 13.
Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β.
Melanson M, Grossberndt A, Klowak M, Leong C, Frost EE, Prout M, Le Dorze JA, Gramlich C, Doupe M, Wong L, Esfahani F, Gomori A, Namaka M.
Int J Neurosci. 2010 Oct;120(10):631-40.
Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Ghabaee M, Jabedari B, Al-E-Eshagh N, Ghaffarpour M, Asadi F.
Int J Neurosci. 2010 Apr;120(4):301-4.
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group.
Yamout BI, Dahdaleh M, Al Jumah MA, Al-Shammri S, Al Sharoqi I, Al-Tahan AR, Bohlega S, Deleu D, Inshasi J, Khalifa A, Szólics M.
Int J Neurosci. 2010 Apr;120(4):273-9.
Prognostic factors of multiple sclerosis in Lebanon.
Yamout B, Itani S, Arabi A, Hamzeh D, Yaghi S.
Int J Neurosci. 2010 Mar;120(3):206-10.
Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G.
Int J Neurosci. 2010 Jan;120(1):71-5.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on